Canget BioTekpharma LLC
CHINESE (中文版)


Partnership:
We welcome partners from pharmaceutical companies and/or other investors to develop anticancer drugs together with Canget BioTekpharma from its pipeline and share the benefits
Contracts:
Provide genetically engineered cancer cell-based drug screening model systems for other pharmaceutical companies to screen their own compound libraries (US Patent No.: US 7,569,221 B2)

Canget BioTekpharma Company Copyright. All rights reserved.